BioSpace News Archive

AEVOLVE, a medical innovation platform, is a platinum sponsor of the second annual World Crypto Conference (WCC), which will attract thousands of digital currency and blockchain technology enthusiasts to the Las Vegas strip October 29 through 31, 2019.

PitchBook, the premier data provider for the private and public equity markets, will release nine Emerging Technology Research reports in Q4 2019 to expand coverage of new sectors, including healthtech, IoT, information security and supply chain tech.

Healthcare workers are injured on the job more than any other profession; Excessive injuries can be prevented, and patient mobility improved with safe patient handling practices

Life science industry investments in digital transformation, such as artificial intelligence and other emerging technologies, may pay off slower than what was once expected, KPMG’s CEO Outlook found.

Applied Medical Technology, Inc. (AMT) announced that it has expanded its ColoCare™ product offering to include a 10F MiniACE® Low Profile Antegrade Continence Enema Button.

Kaiser Permanente today announced it has launched Food for Life, a landmark initiative to increase food security on a national scale.

AstraZeneca today announced positive progression-free survival (PFS) results for IMFINZI and tremelimumab, an anti-CTLA-4 antibody, when added to chemotherapy, from the Phase III POSEIDON trial in previously-untreated Stage IV (metastatic) non-small cell lung cancer (NSCLC).

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the Stifel 2019 Healthcare Conference on Wednesday, November 20, 2019, in New York, NY.

UFC GYM®, the rapidly expanding fitness franchise that creates training programs for all levels and ages inspired by the regimens of UFC® athletes, is excited to announce its partnership with NormaTec, the industry leader in compression recovery technology

SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the third quarter of 2019 after market close on Monday, November 11, 2019.